First Header Logo Second Header Logo

Connection

Michael Cartwright to Muscular Atrophy, Spinal

This is a "connection" page, showing publications Michael Cartwright has written about Muscular Atrophy, Spinal.
Connection Strength

1.767
  1. Cartwright MS, Upadhya S. Selecting disease-modifying medications in 5q spinal muscular atrophy. Muscle Nerve. 2021 Oct; 64(4):404-412.
    View in: PubMed
    Score: 0.810
  2. Cartwright MS, Ward ZT, White EP, West TG. Intrathecal delivery of nusinersen in individuals with complicated spines. Muscle Nerve. 2020 07; 62(1):114-118.
    View in: PubMed
    Score: 0.747
  3. Elman L, Youn B, Proud CM, Frey MR, Ajroud-Driss S, McCormick ME, Michelson D, Cartwright MS, Heiman-Patterson T, Choi JM, Chandak A, Khachatryan A, Martinez M, Paradis AD. Real-world Adherence to Nusinersen in Adults with Spinal Muscular Atrophy in the US: A Multi-site Chart Review Study. J Neuromuscul Dis. 2022; 9(5):655-660.
    View in: PubMed
    Score: 0.210
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.